ONCOTRACK

OncoTrack, an international consortium of over 60 scientists, managed by Bayer AG and the Max Planck Institute for Molecular Genetics, has launched one of Europe's largest collaborative academic-industry research projects to develop and assess novel approaches for identification of new markers for colon cancer. OncoTrack, an international consortium of over 60 scientists, managed by Bayer AG and the Max Planck Institute for Molecular Genetics, has launched one of Europe's largest collaborative academic-industry research projects to develop and assess novel approaches for identification of new markers for colon cancer... We believe that the results of this research will allow the identification and qualification of a set of biomarkers that may be used to guide patient therapy, provide immediate feedback upon the effects of treatment and ultimately indicate likely outcome of disease management - i.e. Oncology Tracking!

Primary location: Berlin Germany